Feedback / Questions
Dupixent (dupilumab) - Sanofi, Regeneron
eblasakimab (ASLAN004) - ASLAN Pharma, Zenyaku Holdings
https://www.globenewswire.com/news-release/2024/04/12/2862146/0/en/ASLAN-Pharmaceuticals-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Corporate-Update.html
Apr 13, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next